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Podocyte damage and apoptosis are thought to be important
if not essential in the development of glomerulosclerosis.
Female estrogen receptor knockout mice develop
glomerulosclerosis at 9 months of age due to excessive
ovarian testosterone production and secretion. Here, we
studied the pathogenesis of glomerulosclerosis in this mouse
model to determine whether testosterone and/or
17b-estradiol directly affect the function and survival of
podocytes. Glomerulosclerosis in these mice was associated
with the expression of desmin and the loss of nephrin,
markers of podocyte damage and apoptosis. Ovariectomy
preserved the function and survival of podocytes by
eliminating the source of endogenous testosterone
production. In contrast, testosterone supplementation
induced podocyte apoptosis in ovariectomized wild-type
mice. Importantly, podocytes express functional androgen
and estrogen receptors, which, upon stimulation by their
respective ligands, have opposing effects. Testosterone
induced podocyte apoptosis in vitro by androgen receptor
activation, but independent of the TGF-b1 signaling
pathway. Pretreatment with 17b-estradiol prevented
testosterone-induced podocyte apoptosis, an estrogen
receptor-dependent effect mediated by activation of the
ERK signaling pathway, and protected podocytes from
TGF-b1- or TNF-a-induced apoptosis. Thus, podocytes are
target cells for testosterone and 17b-estradiol. These
hormones modulate podocyte damage and apoptosis.
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The main sex steroid hormones, 17b-estradiol (E2) and
testosterone (T) modulate the development and progression
of glomerulosclerosis (GS), a disease process largely deter-
mined by genetic traits, age, and sex. E2 via stimulation of
the estrogen receptor (ER) a activates signaling pathways
and regulates genes in glomerular/mesangial cells in a
manner that is protective against GS.1,2 Accordingly, estrogen
deficiency accelerates the progression3 and E2-replacement
retards the development of GS in ovariectomized sclerosis-
prone ROP Os/þ mice.4
In contrast, T from endogenous or exogenous sources
exerts deleterious effects on the glomerulus. Female mice
transgenic for an ERa gene deletion (aERKO) develop GS
because of their elevated blood T levels that are eight times
higher than those of their female littermates.5 Interestingly,
the C57Bl6 (B6) background, which confers glomerular
resistance to noxious stimuli such as diabetes or unilateral
nephrectomy, does not protect female aERKO mice from the
effects of high levels of circulating T.5 Ovariectomy (Ovx)
prevents the onset of glomerular dysfunction in aERKO
females by eliminating their endogenous T production.5 In
contrast, T supplementation induces GS in ovariectomized
B6 mice,5 whereas estrogen deficiency following Ovx had no
deleterious effects on the glomerulus of B6 mice.
The cellular effects of estrogens and T in the pathogenesis
of progressive kidney damage, in these and other studies,
have focused on mesangial cells, for years considered the key
player in the events leading to the progression of renal injury.
In contrast, to our knowledge little data are available on the
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effects of sex hormones on podocytes,6 the cell type whose
role may include initiation of progressive renal disease.7–11
The ability of the kidney to replace damaged or lost
podocytes is limited as podocytes exhibit a reduced potential
to regenerate via mitosis in the glomerulus.8,12 Thus,
progressive podocyte damage characterized by foot process
effacement, vacuolization, and detachment of podocytes
from the glomerular basement membrane, which finally
leads to the irreversible loss of podocytes are now considered
important, if not essential, initial events in the development
and progression of GS.7–12
In this study, we examined the effects of estrogens and T on
podocyte damage and apoptosis. We found that female aERKO
mice show podocyte damage and apoptosis, which was
prevented by Ovx and reproduced in B6 mice by T
supplementation. Moreover, we showed that cultured podocytes
express androgen receptor (AR) and ER, and that estrogens and
T have opposing effects on podocyte apoptosis. Finally, the
involvement of the extracellular signal-regulated protein kinase
(ERK) signaling pathway in these events was evaluated.
RESULTS
Podocyte injury in female aERKO mice
The expression of desmin, a marker of podocyte dedifferentia-
tion and damage,13 was examined to evaluate podocyte injury
in aERKO mice. Little or no expression of desmin was detected
in wild-type (WT) littermates of aERKO mice (Figure 1a). In
contrast, a strong positive signal was seen in glomeruli of
aERKO mice (Figure 1b). Semi-quantitative evaluation of
desmin staining confirmed that desmin neo-expression was
higher in aERKO mice than in controls (Figure 1c).
Nephrin, evaluated by indirect immunofluorescence,
exhibited a glomerular epithelial staining pattern with a
linear distribution along the peripheral capillary loops in
WT littermates of aERKO mice (Figure 1d). In contrast,
in glomeruli of aERKO mice (Figure 1e) there was a
reduction of nephrin immunoreactivity (Figure 1f). Control
sections incubated with the non-immune isotypic control
antibody or with the appropriate labeled secondary antibody
without the primary antibody were always negative (data not
shown). In addition, we assessed the total number of
podocytes per glomerulus by counting the cells expressing
Wilms tumor (WT1), a specific marker of podocytes, and
found that glomeruli of aERKO mice had a decreased
number of WT1-positive cells compared with WT littermates
(Table 1).
Increased podocyte apoptosis in female aERKO mice
There was a 17-fold increase in the average of terminal
dUTP nick-end labeling (TUNEL)-positive podocytes per
glomerular section in aERKO mice compared with their WT
littermates (Figure 2). On the contrary, no TUNEL-positive
cells were detected among the other glomerular cell types or
in the tubular compartment. In addition, we found increased
podocyte-specific caspase 3 expression in aERKO glomeruli
compared with WT littermates (Figure 2d). These results
demonstrate that increased rates of apoptosis in podocytes
are characteristic for this model of GS, and coincided with
increased rates of podocyte damage as determined by desmin
and nephrin immunostaining (see Figure 1).
In vivo effects of T on podocytes
Ovx of aERKO mice reduced both podocyte damage, as
shown by decreased desmin staining score and increased
nephrin expression (Figure 3a and b), and podocyte loss
(Table 1). In addition, the average of TUNEL-positive
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Figure 1 |Podocyte injury in female aERKO mice. Immunohistochemical staining for desmin in glomeruli of female wild-type (WT)
littermates (a) and female aERKO mice (b). Data are the mean±s.e.m. (c). N¼ 5 mice/group. Immunofluorescence staining for nephrin in
glomeruli of female wild-type littermates (d) and female aERKO mice (e). Data are the mean±s.e.m. (f). N¼ 5 mice/group. Original
magnifications:  400. Student’s t-test was performed.
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podocytes per glomerular section was significantly reduced
in Ovx aERKO mice, returning to values similar to
those measured in their WT littermates (Figure 3c). In
contrast, Ovx of WT mice had neither effect on podocyte
injury scores and apoptosis (Figure 3d), nor on podocyte
number (Table 1). Finally, T supplementation of Ovx B6
mice induced a marked increase in both podocyte injury
scores, as determined by desmin and nephrin immuno-
staining, and apoptosis rate (Figure 3d), as well as a
significant reduction in the number of WT1 positive cells,
compared with WT control glomeruli (Table 1). These data
suggest that T action rather than estrogen deficiency has a
predominant role in determining podocyte injury and
apoptosis in vivo.
Estrogens protect podocytes from apoptosis induced by
transforming growth factor (TGF)-b1 and tumor necrosis
factor (TNF)-a
We tested whether E2 protects podocytes from apoptosis
induced by TGF-b1 (10 ng/ml) and TNF-a (10 ng/ml). As
expected, both TGF-b1 and TNF-a were able to induce
apoptosis in cultured podocytes (Figure 4). Pretreatment of
podocytes with physiological concentrations of E2 (1 nmol/l),
significantly reduced the number of cells undergoing
apoptosis after TGF-b1 and TNF-a stimulation (Figure 4).
To determine whether E2-mediated protection from TGF-b1-
and TNF-a-induced apoptosis was an ER-dependent effect,
we incubated podocytes with the transcriptionally inactive
stereoisomer 17a-estradiol, ICI 182780 (1 mmol/l), an
Table 1 |Wilms tumor (WT1)-positive cells per glomerulus in the different experimental groups
aERKO Wild type aERKO/Ovx Wild type/Ovx B6/Ovx+T B6/Ovx
WT1-positive cells/glomerulus 0.7±0.06a,b 3.0±0.40 4.4±0.0.58c 3.9±0.45d 1.4±0.01 2.3±0.49e
Abbreviation: Ovx, ovariectomy.
aPo0.005 compared with WT controls.
bPo0.0005 compared with aERKO/Ovx.
cPo0.005 compared with B6/Ovx+T.
dPo0.005 compared with B6/Ovx+T.
ePo0.05 compared with ERKO or ERKO/Ovx.
P<0.01
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Figure 2 | Increased podocyte apoptosis in female aERKO mice. Podocyte apoptosis in female wild-type (WT) littermates (a) and female
aERKO mice (b), as detected by TUNEL assay. Yellow arrows indicate TUNEL-positive cells, whereas the red arrow indicates an artifactual
staining of a red blood cell. Results are expressed as percentage of number of TUNEL-positive cells on the total number of glomerular
cells and graphed as the mean±s.e.m. (c). N¼ 5 mice/group. Original magnifications:  400. Student’s t-test was performed.
(d) Representative images of caspase 3 immunofluorescence staining and colocalization with synaptopodin expression, used as podocyte
marker, in female WT littermates and female aERKO mice. TUNEL, terminal dUTP nick-end labeling.
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antiestrogen compound devoid of agonist activity, or ICI,
a complete ER antagonist, followed 1 h later by 1 nmol/l
E2-containing medium. We found that equimolar concentra-
tions of the transcriptionally inactive isomer 17a-estradiol
did not protect cells from TGF-b1- and TNF-a-induced
apoptosis. ICI abolished the protective effect of E2 on
TGF-b1- and TNF-a-induced apoptosis (Figure 4), suggest-
ing that this was an ER-dependent effect.
Expression of AR and ER in cultured podocytes
There were 250±42 copies of ERa, 50±10 copies of ERb,
and similar amounts of AR as that described for diabetic
podocytes after estrogen treatment. ER and AR protein was
expressed in cultured podocytes from female B6SJLF1/J
(Figure 5). These data suggest that podocytes, as we had
previously shown for mesangial cells,5 are target cells for sex
steroid hormones.
Proapoptotic effect of T on podocytes
The incubation of cultured podocytes with T (1 nmol/l)
induced a ninefold increase in apoptosis rate as assessed by
the TUNEL assay (Figure 6). The proapoptotic effect of
T on podocytes was abolished by the administration of the
androgen receptor antagonist flutamide (100 nmol/l, Figure 6),
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Figure 3 | Testosterone induces in vivo podocyte injury and apoptosis in female aERKO mice. Desmin (a) and nephrin (b) scores in
glomeruli of female aERKO mice, their female wild-type (WT) littermates, ovariectomized female WT (WT-Ovx) and aERKO mice (ERKO-Ovx),
and Ovx-B6 mice supplemented with T. Desmin and nephrin staining were measured as described in Materials and Methods and expressed
as mean±s.e.m. (c) Number of TUNEL-positive cells per glomerulus in the different experimental groups (mean±s.e.m.). Sections were
analyzed from 5 mice/group, 10 glomeruli/section. ANOVA with Newman-Keuls’ multicomparison test was performed. (d) Representative
images of caspase 3 immunofluorescence staining and colocalization with synaptopodin expression, used as podocyte marker, in female
aERKO mice, their female WT littermates, ovariectomized female WT (WT-Ovx) and aERKO mice (ERKO-Ovx), and Ovx-B6 mice supplemented
with T. ANOVA, analysis of variance; Ovx, Ovariectomy; T, testosterone.
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which restored the apoptosis rate to values similar to those
observed in cells exposed to the vehicle alone (Figure 5).
Pretreatment of podocytes with physiological concentrations
of E2 (1nmol/l), but not 17a-estradiol (1nmol/l), significantly
reduced the number of cells undergoing apoptosis after
T stimulation (Figure 6). This was an ER-mediated effect since
treatment with the complete ER antagonist ICI blocked the
protective effects of E2 on T-induced apoptosis (Figure 6).
Production of TGF-b1
Development of GS in aERKO mice was associated with
increased TGF-b1 expression.5 As TGF-b1 has been shown
to have a major role in inducing podocyte apoptosis,14 we
evaluated whether T induced podocyte TGF-b1 production.
No difference in TGF-b1 production was observed after
T stimulation (data not shown).
Smad7 expression
Smad7 upregulation may induce apoptosis in podocytes
independently from TGF-b1.14 We therefore examined by
reverse transcription PCR whether (a) T directly induced
Smad7 gene transcription, and (b) the proapoptotic effect of
T in podocytes was mediated by increased Smad7 gene
transcription. Reverse transcription PCR experiments showed
that although TGF-b1 (10 ng/ml) induced a threefold
increase in Smad7 gene expression, T stimulation did not
modify Smad7 gene expression in podocytes after 1 and 3 h
of incubation (data not shown).
ERK activation regulates estrogen effects on podocytes
In many cell types, including mesangial cells, estrogens
increase ERK phosphorylation via both nongenomic and
genomic activation.15–17 Thus, we studied whether activation
of ERKwas involved in mediating the antiapoptotic effects of
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Figure 4 | Estrogens protect podocytes from apoptosis
induced by TGF-b1 and TNF-a. Podocytes were treated in vitro
with vehicle (V), TGF-b1 (10 ng/ml), TNF-a (10 ng/ml), E2 (1 nmol/l),
17a-estradiol (17a-E) (17a, 1 nmol/l), ICI 182780 (ICI, 1 mmol/l) or a
combination. Apoptosis was measured in terms of TUNEL-positive
cells (%) (see Materials and Methods for details). Data are the
mean±s.e.m. of 3–5 independent experiments. ANOVA with
Newman-Keuls’ multicomparison test was performed. *Po0.001
compared with vehicle alone, #Po0.001 compared with
TGF-b1 or TNF-a alone, respectively, $Po0.001 compared with
TGF-b1þ E2 or TNF-aþ E2, respectively. Abbreviations: ANOVA,
analysis of variance; E2, 17b-estradiol; TGF, transforming growth
factor; TNF, tumor necrosis factor.
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Figure 5 |Podocytes express androgen (AR) and estrogen
receptors (ER). Cell lysates were collected from cultured
podocytes and western blot analysis performed as described in
Materials and Methods. AR and ER expressions were detected at
the expected molecular weights of 110 kDa (AR), 66 kDa (ERa), and
56 kDa (ERb). Lane 1 and 2 podocyte cell lysates collected from
two independent collections.
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Figure 6 |T induces in vitro podocyte apoptosis. Podocytes
were treated in vitro with vehicle (V), T (1 nmol/l), E2 (1 nmol/l),
flutamide (100 nmol/l), ICI 182780 (ICI, 1 mmol/l), or a combination.
Apoptosis was measured in terms of TUNEL-positive cells (%)
(see Materials and Methods for details). Data are the mean±s.e.m.
of 3–5 independent experiments. ANOVA with Newman-Keuls’
multicomparison test was performed. *Po0.001 compared with
vehicle alone, #Po0.001 compared with T alone, $Po0.001
compared with E2þ T. ANOVA, analysis of variance; E2, 17b-
estradiol; 17a-E2, 17a-estradiol; T, testosterone; TUNEL, terminal
dUTP nick-end labeling.
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E2 on podocytes. Incubation of cultured podocytes with
PD98059, the ERK kinase inhibitor, abolished the protective
effect of E2 against T-induced apoptosis (Figure 7a). Western
blot analysis confirmed that treatment with E2 increased
ERK1/2 activation, both in the presence or absence of
T (Figure 7), suggesting that the protective effect of estrogens
on T-induced apoptosis was, at least partially, mediated by
ERK activation.
DISCUSSION
There is mounting evidence that sex steroid hormones affect
and modulate the development and progression of GS;
however, the molecular mechanism(s) underlying steroid
hormone action on glomerular cells are only partially
elucidated. In this study, we show, to our knowledge for
the first time, that podocytes are target cells for T and E2, and
that these sex steroid hormones are implicated in the
pathogenesis of podocyte damage and apoptosis, thus
influencing the pathophysiology of GS.
Podocytes have a pivotal role in the early functional and
structural changes of kidney disease. In humans, podocyte
loss closely correlates with the degree of progression in
type 2 diabetic Pima Indians,18 type 1 diabetics,19 and IgA
nephropathy patients.20 Induction of selective podocyte
depletion by transgenic expression of CD25 or human
diphteria toxin receptor and subsequent stimulation with
anti-CD25 antibody or diphteria toxin,21,22 leads to patho-
logical features of GS and progressive loss of renal function.
Experimental studies have focused on the molecular
mechanisms underlying podocyte damage and loss, stressing
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Figure 7 | E2-induced ERK activation protects podocytes from apoptosis. Podocytes were treated with either vehicle (V), T (1 nmol/l), E2
(1 nmol/l), PD98059 (PD), or a combination. (a) Apoptosis was measured as % TUNEL-positive cells. Podocytes were counted as
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the importance of podocyte apoptosis as a major factor
leading to a decrease in podocyte number. Podocyte
apoptosis has been detected during the early stages of
progressive GS and peaks by the time of onset of proteinuria
in TGF-b1-overexpressing,14 CD2AP-deficient,23 and diabetic
Akita and db/db mice.24 In vitro, a variety of stimuli,
including angiotensin II,25 oxygen radicals, 26,27 mechanical
stretch,28 cyclosporin A,29 TGF-b1, and related signaling
molecules,14 are able to directly induce apoptosis in
podocytes.
In this study we found that in female aERKO mice,
podocyte damage and apoptosis participate in the develop-
ment of GS. In these mice, the development of functional
(increased urinary albumin excretion) and histological
features (increased glomerular volume and ECM accumula-
tion) of progressive GS5 were indeed associated with markers
of podocyte damage, namely desmin neo-expression, nephrin
loss, and reduced number of WT1-positive cells. Moreover,
the rate of apoptosis in podocytes, as determined by TUNEL
assay and podocyte specific caspase 3 expression, was
significantly higher in female aERKO mice than in their
WT littermates.
We previously reported that the development of GS in
aERKO mice was related to their increased endogenous T
production rather than to estrogen deficiency.5 Ovx pre-
vented the onset of glomerular dysfunction in aERKO
females, whereas T supplementation induced GS in ovar-
iectomized B6 mice.5 In this study, we also found that Ovx
prevented the decrease in podocyte number, evaluated as
WT1-positive cells, in aERKO females, whereas T supple-
mentation induced podocyte loss in ovariectomized B6 mice.
Therefore, it would appear that podocyte damage and
apoptosis in aERKO mice is mediated through androgen
action rather than by estrogen deficiency. It cannot be
excluded, however, that in other experimental or pathological
settings, the lack of an estrogen protective effect per se could
represent an important pathogenetic factor for the develop-
ment of podocyte dysfunction and progressive GS.
The results of the present study extend our previously
reported data on the glomerulus and mesangial cells as direct
targets for T, by demonstrating, for the first time to our
knowledge, the mRNA and protein expression of AR in
podocytes. Effects of T on podocytes have been previously
shown in a study by de Ruiter. Podocyte secretory activity
(as evidenced by increased Golgi apparatus) was stimulated
in vivo by T in male sticklebacks.30 Another important
finding of our study is the demonstration that physiological
concentrations of T directly induce apoptosis of podocytes
in vivo and in vitro. This appears to be an AR-dependent
effect as it was blocked by AR inhibition with flutamide.
Verzola et al. have shown a direct proapoptotic effect of T in
human tubular cells,31 but there are no previously published
studies on glomerular cells.
We have previously shown that podocytes isolated from a
model of type 2 diabetes and littermate controls express both
ERa and ERb subtypes.6 In addition, Gross et al. showed that
estriol treatment prevented podocyte loss and injury in
uninephrectomized ovariectomized rats.32 These data suggest
that podocytes may be potential targets of estrogen action.
Our results showed that the pretreatment of podocytes
with physiological concentrations of E2, but not with its
transcriptionally inactive stereoisomer 17a-estradiol, pre-
vented podocyte apoptosis induced by T as well as by TGF-b1
and TNF-a. This was an ER-dependent effect, as ICI, a
complete estrogen antagonist, abolished the protective effect
of E2. Previous studies showed that estrogens are able to
prevent apoptosis in a variety of cell types, including
mesangial and tubular cells.31,33 As our results clearly showed
that podocytes are direct targets of estrogen action, we
speculate that the observed protective effects exerted in vivo
by estrogen replacement therapy in several experimental
models of renal disease3,4,34–36 may also be related to its
action on podocytes. Moreover, the pretreatment of podo-
cytes with E2 was able to prevent the apoptosis induced by T,
suggesting that the balance between estrogens and Tmay have
a relevant pathogenetic role in vivo. Interestingly, T produc-
tion by the ovaries persists in women after menopause
thereby changing the ratio of E2 to T in favor of T. This
phenomenon may therefore potentially contribute to the
faster progression of chronic kidney disease in women after
menopause.37–41
We also evaluated whether T might induce TGF-b1
production, which has been shown to induce podocyte
apoptosis.14 Although mesangial cells isolated from aERKO
mice had increased TGF-b1 expression that was prevented by
Ovx,35 we found no change in TGF-b1 production after
podocyte stimulation with T. In addition, Smad7, the
negative regulator of TGF-b1/Smad signaling42 was not
upregulated by T, although it has been shown to induce
apoptosis in podocytes both independently from and in
cooperation with TGF-b1.14 Therefore, our data suggest that
the T proapoptotic effect is not mediated by the regulation of
podocyte TGF-b1 production; however, we can not exclude
that, in vivo, TGF-b1 and T may have an additive or
synergistic effect on podocyte apoptosis and GS progression.
Estrogens are known to induce activation of ERK via both
nongenomic and genomic effects;15–17 thus, we studied
whether ERK activation was involved in the antiapoptotic
action of estrogens in podocytes. Western blot analysis
revealed that treatment with E2 increased ERK1/2 activation;
both in the presence or absence of T, suggesting this signaling
pathway mediated the protective effect of estrogens on
T-induced apoptosis.
Other groups have previously studied blood pressure
levels in female aERKO mice and reported no difference in
basal mean arterial pressure in both intact and ovariecto-
mized aERKO mice compared with WT.43,44 Only Ovx
aERKO mice treated with E2 had significantly smaller resting
mean arterial pressure, suggesting an effect of estrogen on
resting vascular tone possibly mediated by the ERb subtype.43
On the other hand, it has been shown that ERa mediates the
protective effects of estrogens against angiotensin II-induced
410 Kidney International (2011) 79, 404–413
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hypertension.44 Therefore, we can not exclude that the lack of
this protective effect may also contribute to the development
of podocyte injury and GS in aERKO mice.
In conclusion, we showed that, in aERKO mice, the
progression of GS is associated with the appearance of markers
of podocyte damage and apoptosis, which, in this experimental
model, are related to excessive androgen stimulation and not
to estrogen deficiency. We characterized at the cellular level the
opposing effects that estrogens and T exert on podocyte
apoptosis. In particular, we showed that estrogens protect
podocytes from apoptosis induced by TGF-b1, TNF-a, and T,
and that T is able to directly induce podocyte apoptosis
in vitro. These findings show that podocytes are direct targets
of estrogen and androgen action and implicate sex hormones,
for the first time, in the pathogenesis of podocyte damage
and apoptosis.
MATERIALS AND METHODS
ICI 182780 (ICI) was obtained from Tocris (Ballwin, MO), and
PD98059 (PD) from Calbiochem (La Jolla, CA). Antigen retrieval
solution (Retrieve-ALL-1) was from Signet Laboratories (Dedlham,
MA). The TUNEL assay (ApoTag) was from Oncor (Gaithersburg,
MD). Antibodies anti-mouse WT1, anti-ERK and pERK, anti-AR,
and protein A/G-agarose were obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA). Anti-caspase 3, anti-synaptopodin, and
anti-desmin antibodies were from Cell Signaling Technology
(Beverly, MA), Novus Biologicals (Littleton, CO), and DAKO
(Gostrup, Denmark), respectively. An irrelevant IgG1 isotypic
control antibody was purchased from Cedarlane (Hornby, Ontario,
Canada). Phenol red-free DMEM/Ham’s F-12 medium (B medium)
was purchased by Invitrogen Life Technologies (Grand Island, NY),
and dextran–charcoal stripped fetal bovine serum (FBS) from
HyClone (Pittsburgh, PA). TGF-b1 ELISA assay was from R&D
Systems (Minneapolis, MN). All other reagents were purchased from
Sigma–Aldrich (St Louis, MO).
Animals
Female ERKO mice and their WT littermates were obtained from
Taconic farms (Germantown, NY).5 B6 mice were obtained from
Jackson Laboratories (Bar Harbor, ME). Female aERKO,
WT littermates, and B6 mice were ovariectomized at 3–4 months
of age using the previously described procedure approved by the
Committee for Animal Safety at the University of Miami School of
Medicine.5 Placebo, E2 (0.05mg/pellet), or T (12.5mg/pellet)
was administered to the mice via 90-day time-release pellets
(Innovative Research of America, Sarasota, FL) as previously
described.5 Mice were allowed free food and water and were killed
at 9 months of age, as previously detailed.5 As we described
previously, aERKO serum T levels were approximately eight times
higher than that of female littermates. T supplementation of Ovx B6
mice increased T to levels approximately threefold higher than those
of Sham B6 mice.
T and E2 levels were significantly decreased in Ovx aERKO mice.
As expected, E2 supplementation resulted in increased uterine
weight in WT littermate mice, but not in aERKO mice.5
Histopathology
Desmin immunostaining was performed by standard immunohis-
tochemical procedure and analyzed by a renal pathologist blinded to
the origin of the kidney slides using the following semiquantitative
scoring system (0–3): score 0: no expression, score 1: weak
expression, score 2: moderate expression, score 3: strong expression.
The average value of the desmin score in 50 randomly selected
nonsclerotic glomeruli in each animal was taken to represent the
degree of podocyte injury.45
Nephrin staining was evaluated by indirect immunofluorescence
in 2 mm-thick cryostat sections fixed in 3.5% paraformaldehyde for
15min and then washed in phosphate-buffered saline, as previously
described.46 Control experiments included incubation of sections
with nonimmune isotypic control antibodies or the omission of
primary antibodies followed by the appropriate labeled secondary
antibodies. Nephrin staining in each glomerulus was scored from 0
to 3 by a renal pathologist blinded to the origin of the kidney slides
and the average value of the nephrin score in 50 randomly selected
glomeruli in each animal was taken.
For WT1 detection, slides were deparaffinized, exposed to
antigen retrieval solution, blocked with 0.3% H2O2 for 30min to
block endogenous peroixidase, and incubated with a rabbit anti-
mouse WT1 antibody overnight. Slides were then washed, exposed
to a biotinylated rabbit antibody, followed by Vectastain elite ABC
reagent.
Apoptosis detection
Apoptosis was evaluated by TUNEL assay following the manufac-
turer’s protocol. Podocytes were counted as apoptotic only when
nuclear labeling by 40-6-diamidino-2-phenylindole (blue) and
nuclear TUNEL labeling (green) colocalized resulting in turquoise
nuclei.14 Results are expressed as percentage of number of TUNEL-
positive cells on the total number of glomerular cells. The expression
of caspase 3, one of the caspases involved in the apoptosis signaling
cascade, was also evaluated by standard immunofluorescence
techniques. Synaptopodin expression, detected by indirect immu-
nofluorescence, was used as a podocyte marker and the merge of
caspase 3 and synaptopodin staining was considered a sign of
podocyte specific expression of caspase 3.
Cell culture and experimental in vitro conditions
Glomerular epithelial cells isolated from 6-week-old female
B6SJLF1/J mice were used at passages 23–25.47 At 3 days before
apoptosis detection, cells were plated in eight-well Permanox slide at
a density of 25 000 cells per well in phenol red-free B medium
containing 20% dextran–charcoal stripped FBS.1 In the evening
before the experiment, the medium was replaced with phenol
red-free B medium containing 0.1% dextran–charcoal stripped FBS.
For induction of apoptosis, cells were incubated with vehicle
control (0.001% ethanol), TGF-b1 (10 ng/ml), TNF-a (10 ng/ml), or
T (1 nmol/l) for 24 h. In selected experiments, the cells were
incubated with vehicle control (0.001% ethanol), E2 (1 nmol/l), ICI
(1mmol/l), ICI followed 1 h later by E2 (1 nmol/l), or 17a-estradiol
(1 nmol/l) for 2 h before stimulation with TGF-b1 (10 ng/ml), TNF-
a (10 ng/ml), or T (1 nmol/l) for 24 h. In some experiments, cells
were exposed to 100mmol/l flutamide for 4 h before incubation
with T (1 nmol/l), or with 40 mmol/l PD for 30min before
incubation with E2 (1 nmol/l).
To evaluate Smad7 gene expression, cells were plated in 25 cm2
dishes at a concentration of 300 000 cells per dish in phenol red-free
B medium containing 20% dextran–charcoal stripped FBS and
grown for 3 days. In the evening before the experiment, the medium
was replaced with phenol red-free B medium containing 0.1%
dextran–charcoal stripped FBS. Cells were then incubated with
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vehicle control (0.001% ethanol), TGF-b1 (10 ng/ml), or T (1 nmol/l)
for 1 and 3 h. In selected experiments cells were incubated with
vehicle control (0.001% ethanol) or E2 (1 nmol/l) for 2 h before
stimulation with TGF-b1 (10 ng/ml) or T (1 nmol/l).
Isolation of RNA and quantitative analysis of RNA expression
by real-time reverse transcription PCR
Total RNA was extracted from cultured podocytes isolated from
female B6SJLF1/J mice using the guanidinium thiocyanate–phenol–-
chloroform method as described. Amplification and quantification
of target RNAs was performed on an ABI PRISM 7700 Sequence
Detection System (Applied Biosystems, Foster City, CA).1 Copy
number for ERa, ERb, and AR was determined as previously
described.6 TaqMan ribosomal RNA control reagents to detect 18S
ribosomal RNA served as an endogenous control to normalize for
variations in the isolated RNA amount.
Western blot analysis
To determine the presence of AR and ER subtypes a and b, and to
assess ERK activation in cultured podocytes, we performed western
blot analysis as previously described.6
Statistical analysis
All data are expressed as mean±s.e.m. Significance of differences
between experimental groups was determined by analysis of variance
in combination with Newman-Keuls’ multiple comparison test or by
Student’s t-test. A P-value o0.05 was considered significant.
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